GlassScriptPhysician profile
Blaine L Farless
NPI 1881633766
$3,399.67
in general payments reported to CMS, 2019-2025
27 companies · $321 in 2025
The $321 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $92.74 · 2021: $148 · 2022: $491 · 2023: $90.15 · 2024: $1,986 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,542 · Travel and Lodging: $855.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,542.15 |
| Travel and Lodging | $854.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,104.70 | 2024 | |
| Pylant Medical | $610.50 | 2024-2025 | |
| Abbvie INC. | $241.79 | 2021-2022 | |
| Stryker Corporation | $205.42 | 2019-2025 | Alphavent |
| Depuy Synthes Sales INC. | $162.83 | 2019-2024 | Na, Monovisc |
| Ferring Pharmaceuticals INC. | $138.35 | 2021-2025 | Euflexxa |
| Medical Device Business Services, INC. | $127.32 | 2024 | Surgicel Nu-Knit |
| Grt US Holding, INC. | $89.61 | 2022 | |
| Ethicon US, LLC | $88.55 | 2023-2024 | Stratafix, Dermabond Prineo, Surgiflo Hemostatic Matrix |
| Highridge Medical LLC | $87.95 | 2024 | Biomet Orthopak Non-Invasive Bone Growth Stimulator System |
| Pacira Pharmaceuticals Incorporated | $75.31 | 2020-2025 | Exparel |
| Pacira Therapeutics, INC. | $72.29 | 2019-2020 | |
| Abbott Laboratories | $54.08 | 2020-2022 | |
| Horizon Therapeutics Plc | $42.84 | 2019 | |
| Bioventus LLC | $42.55 | 2019-2025 | Exogen Ultrasound Bone Healing System |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $32.93 | 2019-2021 | |
| Integra Lifesciences Corporation | $31.71 | 2022 | |
| Boston Scientific Corporation | $27.50 | 2022 | |
| Rayner Intraocular Lenses Limited | $26.98 | 2024 | Rayone Emv, Rayone Aspheric, Rayner Cataract Set 1 |
| Acell, INC. | $24.24 | 2020 | |
| Baxter Healthcare | $21.60 | 2022 | |
| Zimmer Biomet Holdings, INC. | $20.46 | 2021 | |
| Heraeus Medical, LLC. | $16.59 | 2022 | |
| Fidia Pharma USA INC. | $14.87 | 2019 | |
| Pfizer INC. | $14.52 | 2019 | |
| Merck Sharp & Dohme LLC | $12.94 | 2019 | |
| Vericel Corporation | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blaine Farless listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.